British Journal of Cancer - Table of Contents alert Volume 105 Issue 12

TABLE OF CONTENTS Volume 105, Issue 12 (1805-1960) Published online 6 December 2011 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Author Index Keyword Index Also new today Advance online publication Advertisement 13th Milan Breast Cancer Conference We look forward to meeting you in Milan (Italy) from 22nd to 24th June 2011. For more information please visit the website www.breastmilan.com Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement British Journal of Cancer presents: Web Focus on Angiogenesis Angiogenesis is important for tumour growth and metastasis and is a key target for therapy. Greater understanding of the biology of angiogenesis has highlighted new targets for therapy and key interactions with VEGF, providing new avenues for improving the therapeutic performance of anti-VEGF therapies. This collection brings together a selection of key articles recently published in BJC. Read the articles for FREE   Minireview Top Notch signalling in cancer progression and bone metastasis N Sethi and Y Kang Br J Cancer 2011 105: 1805-1810; advance online publication, November 10, 2011; 10.1038/bjc.2011.497 Abstract | Full Text Clinical Studies Top Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib F Di Fiore, O Rigal, C Ménager, P Michel and C Pfister Br J Cancer 2011 105: 1811-1813; advance online publication, November 17, 2011; 10.1038/bjc.2011.507 Abstract | Full Text Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer A Vodermaier, W Linden, R MacKenzie, D Greig and C Marshall Br J Cancer 2011 105: 1814-1817; advance online publication, November 17, 2011; 10.1038/bjc.2011.503 Abstract | Full Text Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers E-I Braicu, J Sehouli, R Richter, K Pietzner, C Denkert and C Fotopoulou Br J Cancer 2011 105: 1818-1824; advance online publication, November 1, 2011; 10.1038/bjc.2011.455 Abstract | Full Text Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy A Balakrishnan and D Ravichandran Br J Cancer 2011 105: 1825-1829; advance online publication, November 8, 2011; 10.1038/bjc.2011.470 Abstract | Full Text Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours Y Pan, R Xu, M Peach, C-P Huang, D Branstetter, W Novotny, R S Herbst, S G Eckhardt and P M Holland Br J Cancer 2011 105: 1830-1838; advance online publication, October 27, 2011; 10.1038/bjc.2011.456 Abstract | Full Text Translational Therapeutics Top Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo E Arai, Y Nishida, J Wasa, H Urakawa, L Zhuo, K Kimata, E Kozawa, N Futamura and N Ishiguro Br J Cancer 2011 105: 1839-1849; advance online publication, November 1, 2011; 10.1038/bjc.2011.459 Abstract | Full Text PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer A A Memon, B Weber, M Winterdahl, S Jakobsen, P Meldgaard, H H T Madsen, S Keiding, E Nexo and B S Sorensen Br J Cancer 2011 105: 1850-1855; advance online publication, November 17, 2011; 10.1038/bjc.2011.493 Abstract | Full Text Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-β signalling A C Weidenaar, A ter Elst, K R Kampen, T G J Meeuwsen-de Boer, H J M de Jonge, F J G Scherpen, W F A den Dunnen, W A Kamps and E S J M de Bont Br J Cancer 2011 105: 1856-1863; advance online publication, November 1, 2011; 10.1038/bjc.2011.460 Abstract | Full Text Molecular Diagnostics Top Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients A Kolk, N Jubitz, K Mengele, K Mantwill, O Bissinger, M Schmitt, M Kremer and P S Holm Br J Cancer 2011 105: 1864-1873; advance online publication, November 17, 2011; 10.1038/bjc.2011.491 Abstract | Full Text High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives Z Janjetovic, A A Brozyna, R C Tuckey, T-K Kim, M N Nguyen, W Jozwicki, S R Pfeffer, L M Pfeffer and A T Slominski Br J Cancer 2011 105: 1874-1884; advance online publication, November 17, 2011; 10.1038/bjc.2011.458 Abstract | Full Text E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma K Araki, T Shimura, H Suzuki, S Tsutsumi, W Wada, T Yajima, T Kobayahi, N Kubo and H Kuwano Br J Cancer 2011 105: 1885-1893; advance online publication, November 8, 2011; 10.1038/bjc.2011.452 Abstract | Full Text Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry C L Silva, M Passos and J S Câmara Br J Cancer 2011 105: 1894-1904; advance online publication, November 15, 2011; 10.1038/bjc.2011.437 Abstract | Full Text Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients’ survival J Ren, W Li, L Yan, W Jiao, S Tian, D Li, Y Tang, G Gu, H Liu and Z Xu Br J Cancer 2011 105: 1905-1911; advance online publication, November 10, 2011; 10.1038/bjc.2011.492 Abstract | Full Text Genetics and Genomics Top Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families A C Houweling, L M Gijezen, M A Jonker, M B A van Doorn, R A Oldenburg, K Y van Spaendonck-Zwarts, E M Leter, T A van Os, N C T van Grieken, E H Jaspars, M M de Jong, E M H F Bongers, P C Johannesma, P E Postmus, R J A van Moorselaar, J-Htm van Waesberghe, T M Starink, M A M van Steensel, J J P Gille and F H Menko Br J Cancer 2011 105: 1912-1919; 10.1038/bjc.2011.463 Abstract | Full Text PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy M J Fidler, L E Morrison, S Basu, L Buckingham, K Walters, M Batus, K K Jacobson, S S Jewell, J Coon, IV and P D Bonomi Br J Cancer 2011 105: 1920-1926; advance online publication, November 17, 2011; 10.1038/bjc.2011.494 Abstract | Full Text Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia H-A Hou, Y-Y Kuo, C-Y Liu, M C Lee, J-L Tang, C-Y Chen, W-C Chou, C-F Huang, F-Y Lee, M-C Liu, M Yao and H-F Tien Br J Cancer 2011 105: 1927-1933; advance online publication, November 17, 2011; 10.1038/bjc.2011.471 Abstract | Full Text Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk K N Stevens, M Garcia-Closas, Z Fredericksen, M Kosel, V S Pankratz, J L Hopper, G S Dite, C Apicella, M C Southey, M K Schmidt, A Broeks, L J Van ‘t Veer, R A E M Tollenaar, P A Fasching, M W Beckmann, A Hein, A B Ekici, N Johnson, J Peto, I dos Santos Silva, L Gibson, E Sawyer, I Tomlinson, M J Kerin, S Chanock, J Lissowska, D J Hunter, R N Hoover, G D Thomas, R L Milne, JI Arias Pérez, A González-Neira, J Benítez, B Burwinkel, A Meindl, R K Schmutzler, C R Bartrar, U Hamann, Y D Ko, T Brüning, J Chang-Claude, R Hein, S Wang-Gohrke, T Dörk, P Schürmann, M Bremer, P Hillemanns, N Bogdanova, J V Zalutsky, Y I Rogov, N Antonenkova, A Lindblom, S Margolin, A Mannermaa, V Kataja, V-M Kosma, J Hartikainen, G Chenevix-Trench, X Chen, P Peterlongo, B Bonanni, L Bernard, S Manoukian, X Wang, J Cerhan, C M Vachon, J Olson, G G Giles, L Baglietto, C A McLean, G Severi, E M John, A Miron, R Winqvist, K Pylkäs, A Jukkola-Vuorinen, M Grip, I Andrulis, J A Knight, G Glendon, A M Mulligan, A Cox, I W Brock, G Elliott, S S Cross, P P Pharoah, A M Dunning, K A Pooley, M K Humphreys, J Wang, D Kang, K-Y Yoo, D-Y Noh, S Sangrajrang, V Gabrieau, P Brennan, J McKay, H Anton-Culver, A Ziogas, F J Couch and D F Easton the GENICA Network, kConFab Investigators, Australian Ovarian Cancer Study Group Br J Cancer 2011 105: 1934-1939; advance online publication, October 27, 2011; 10.1038/bjc.2011.448 Abstract | Full Text Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study) G Schleiermacher, J Michon, A Ribeiro, G Pierron, V Mosseri, H Rubie, C Munzer, J Bénard, N Auger, V Combaret, I Janoueix-Lerosey, A Pearson, D A Tweddle, N Bown, M Gerrard, K Wheeler, R Noguera, E Villamon, A Cañete, V Castel, B Marques, A de Lacerda, G P Tonini, K Mazzocco, R Defferrari, B de Bernardi, A di Cataldo, N van Roy, B Brichard, R Ladenstein, I Ambros, P Ambros, K Beiske, O Delattre and J Couturier Br J Cancer 2011 105: 1940-1948; advance online publication, November 10, 2011; 10.1038/bjc.2011.472 Abstract | Full Text Author Index Top Author Index for Volume105 Br J Cancer 2011 105: 1949-1956; 10.1038/bjc.2011.539 Full Text Keyword Index Top Keyword Index for Volume 105 Br J Cancer 2011 105: 1957-1960; 10.1038/bjc.2011.540 Full Text Advertisement Ensure your access to British Journal of Cancer If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now at http://www.nature.com/librec/svc/request/makeCommRequest?id=2.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.